Abstract
BackgroundTo evaluate the intraocular concentration of triamcinolone acetonide after intravitreal injection. MethodsThe prospective clinical interventional case series study included 17 patients who had received a 20 to 25-mg intravitreal injection of triamcinolone acetonide as treatment for exudative age-related macular degeneration, diffuse diabetic macular edema, or retinal vein occlusions. During a secondary intraocular surgery taking place 4.1 weeks to 25.7 months after the intravitreal injection, aqueous humor samples were obtained. None of the eyes were vitrectomized. ResultsIn the aqueous humor samples, triamcinolone acetonide was in low, but measurable, concentrations detected up to 1.5 years after the intravitreal injection. Concentrations found in samples obtained during the first 6 months, or 7 to 12 months, respectively, after the injection ranged between 3.0 μg/l and 436 μg/l, and between 0.0 μg/l and 11.2 μg/l, respectively. ConclusionsAfter injection of triamcinolone acetonide, triamcinolone can be present in measurable concentrations up to 1.5 years after the application.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
